Is the business good?
How good a business is PRAX?
Praxis Precision Medicines, Inc. earns −51% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
−51%
Return on invested capital · cost of capital 9.0% · 60 points below what the capital costs: growth destroys value
- Share count, year on year
- +36%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$305M
- Net income, trailing twelve months
- −$339M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −51%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.